Skip to main content
    J

    Janux Therapeutics Inc (JANX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $10.92
    -0.45 (-3.96%)

    Market Cap: $695.65M

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Janux Therapeutics Inc (JANX) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Janux Therapeutics (JANX) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Janux Therapeutics reported EPS of -$0.34, above the -$0.45 estimate. It beat the EPS estimate in 6 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    73%(16/22)
    Avg Surprise
    +9.54%
    Streak
    1 Q

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.54
    Range-$0.79 - $0.14
    20 analysts
    Revenue Consensus
    $7.53M
    RangeN/A
    17 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.58
    Range-$0.66 - -$0.52
    7 analysts
    EPS Estimate DriftChange to current
    90d ago-$0.64+9.1%
    60d ago-$0.63+8.5%
    30d ago-$0.63+8.5%
    7d ago-$0.63+8.5%
    Current-$0.58
    Revenue Consensus
    $2.73M
    RangeN/A
    7 analysts

    Next Report

    JANX has an expected report date of Feb 24, 2027.

    Earnings History

    Of the 22 quarters below that had an estimate, JANX beat 16 and missed 6. Revenue for the quarter ended Sep 30, 2026 was $9.29M, down 7.1% from $10.00M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026-$0.34-$0.45-$0.67 - -$0.04+24.44%BeatN/A144 up, 7 downNov 5, 2026$9.29M
    Jun 30, 2026-$0.35-$0.26-$0.66 - $0.16-34.62%MissN/A141 up, 1 downAug 6, 2026$10.27M
    Mar 31, 2026-$0.39-$0.52-$0.66 - -$0.36+25.00%BeatN/A101 up, 0 downMay 7, 2026$3.73M
    Dec 31, 2025-$0.51-$0.65-$0.94 - -$0.43+21.54%BeatN/A128 up, 3 downFeb 26, 2026$7.88M
    Sep 30, 2025-$0.39-$0.61-$1.02 - -$0.43+36.07%BeatN/A111 up, 6 downNov 6, 2025$10.00M
    Jun 30, 2025-$0.55-$0.48-$0.69 - -$0.32-14.58%MissN/A80 up, 4 downAug 7, 2025N/A
    Mar 31, 2025-$0.38-$0.39-$0.48 - -$0.31+2.56%BeatN/A62 up, 3 downMay 8, 2025N/A
    Dec 31, 2024-$0.36-$0.43-$0.67 - -$0.35+15.59%BeatN/A90 up, 1 downFeb 27, 2025N/A
    Sep 30, 2024-$0.51-$0.36-$0.44 - -$0.14-41.67%MissN/A110 up, 0 downNov 6, 2024$439000
    Jun 30, 2024-$0.11-$0.29-$0.40 - -$0.19+62.07%BeatN/A80 up, 0 downAug 7, 2024$8.90M
    Mar 31, 2024-$0.30-$0.33-$0.39 - -$0.27+9.09%BeatN/A80 up, 0 downMay 7, 2024$1.25M
    Dec 31, 2023-$0.25-$0.39-$0.48 - -$0.30+35.90%BeatN/A50 up, 0 downMar 8, 2024$2.46M
    Sep 30, 2023-$0.25-$0.43-$0.50 - -$0.38+41.86%BeatN/A40 up, 0 downNov 7, 2023$2.52M
    Jun 30, 2023-$0.42-$0.51-$0.61 - -$0.43+17.65%BeatN/A40 up, 0 downAug 8, 2023$1.06M
    Mar 31, 2023-$0.42-$0.46-$0.51 - -$0.44+8.70%BeatN/A40 up, 0 downMay 9, 2023$2.05M
    Dec 31, 2022-$0.39-$0.49-$0.58 - -$0.41+20.41%BeatN/A40 up, 0 downMar 10, 2023$2.85M
    Sep 30, 2022-$0.40-$0.53-$0.53 - -$0.45+24.53%BeatN/A30 up, 0 downNov 10, 2022$1.81M
    Jun 30, 2022-$0.41-$0.39-$0.39 - -$0.35-5.13%MissN/A30 up, 0 downAug 9, 2022$2.37M
    Mar 31, 2022-$0.32-$0.37-$0.37 - -$0.36+13.51%BeatN/A30 up, 0 downMay 10, 2022$1.59M
    Dec 31, 2021-$0.33-$0.31-$0.33 - -$0.29-6.45%MissN/A3N/AMar 18, 2022$1.62M
    Sep 30, 2021-$0.26-$0.17-$0.19 - -$0.17-52.94%MissN/A3N/ANov 9, 2021$1.16M
    Jun 30, 2021-$0.15-$0.16-$0.19 - -$0.07+6.25%BeatN/A2N/AAug 10, 2021$482000
    Mar 31, 2021-$2.02N/AN/AN/AN/AN/AN/AN/AJun 11, 2021$380000
    Dec 31, 2020-$2.63N/AN/AN/AN/AN/AN/AN/AMar 30, 2021N/A
    Dec 31, 2019-$2.20N/AN/AN/AN/AN/AN/AN/AMar 30, 2020N/A
    Last 25 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.83, after -$1.28 the year before. It was -$2.20 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.83N/A
    Dec 31, 2024-$1.28N/A
    Dec 31, 2023-$1.34N/A
    Dec 31, 2022-$1.52N/A
    Dec 31, 2021-$2.76N/A
    Dec 31, 2020-$2.63N/A
    Dec 31, 2019-$2.20N/A

    Frequently Asked Questions About JANX

    When is Janux Therapeutics's next earnings date?

    Janux Therapeutics's next earnings report is expected for Feb 24, 2027.

    Did JANX beat earnings estimates last quarter?

    Yes. Janux Therapeutics reported EPS of -$0.34 for the quarter ended Sep 30, 2026, above the -$0.45 estimate, a 24.44% surprise.

    What EPS do analysts expect from JANX next quarter?

    The consensus EPS estimate for Janux Therapeutics for the quarter ending Dec 31, 2026 is -$0.54 from 20 analysts, with estimates from -$0.79 to $0.14.

    How often does JANX beat earnings estimates?

    Janux Therapeutics beat the EPS estimate in 6 of the last 8 quarters, with an average surprise of +9.50%.